postpartum depression
you are supposed to be flooded with love and instead you are flooded with dread, or with nothing at all. everyone is asking how the baby is sleeping. nobody is asking how you are, and you have started building the sentence in your head and abandoning it, because saying it out loud sounds like an admission that you should not have done this.
it is not an admission. it is common enough that it has been measured in more than a million women across 80 countries. here is what that measurement says.
roughly one in six — and it does not stop at six weeks
pooling 565 studies of 1,236,365 women across 80 countries, postpartum depression affected 17.22% (95% CI 16.00–18.51)[1]. rates varied enormously by place, reaching 39.96% in Southern Africa.
the detail that matters more than the headline: prevalence stayed broadly flat across the whole first year — 17.70% at 1–3 months, 15.31% at 3–6 months, 18.19% at 6–12 months[1]. this is not a condition that reliably declares itself in the early weeks and then fades. screening concentrated at the six-week check is looking in one place for something spread across twelve months.
the caveat, stated plainly: most of those studies used self-report screening scales rather than diagnostic interviews, so this is a symptom-threshold prevalence and will run higher than the rate of diagnosed major depression.
“I have never been depressed before” is weaker protection than you think
one analysis restricted itself to 58 studies of 37,294 mothers with no prior history of depression who delivered healthy full-term infants. prevalence was 17% (95% CI 15–20%) and the incidence of new cases 12% (95% CI 4–20%)[2] — essentially the same as the all-comers global figure.
that incidence interval is very wide, and prevalence differed sharply by region (26% in the Middle East versus 8% in Europe), so the single number hides real variation. but the direction is not ambiguous: a clean psychiatric history is not the shield people treat it as, and it should not be the reason nobody watches you closely.
what has evidence behind it
therapy, and started after the birth. across 40 randomised and quasi-randomised trials of CBT during pregnancy and the first postpartum year, CBT significantly reduced depressive symptoms compared with control conditions, in both treatment and prevention trials, and women who received preventive CBT had significantly lower rates of postpartum depressive episodes. interventions started after the birth outperformed those started during pregnancy, and in prevention trials one-to-one delivery beat group formats[3]. the trials varied widely in quality, which the author says outright.
a trained peer on the phone. 701 Ontario mothers screened as high-risk for postnatal depression were randomised to proactive telephone support from a trained volunteer who had herself recovered from postnatal depression, or to usual care. at 12 weeks, 14% of the peer-support group scored above the depression threshold versus 25% of controls — a number needed to treat of 8.8 (95% CI 5.9 to 19.6). over 80% of the women who received it were satisfied and would recommend it[4].
prevention, formally recommended. the US Preventive Services Task Force issued a B recommendation that clinicians provide or refer pregnant and postpartum people at increased risk of perinatal depression to counselling interventions, finding convincing evidence that CBT and interpersonal therapy prevent it and no more than small potential harms[5]. increased risk includes a history of depression, current depressive symptoms, or socioeconomic factors such as low income or young or single parenthood.
the same statement judged the evidence inadequate for non-counselling prevention approaches — physical activity, education, infant sleep training, nortriptyline, sertraline and omega-3s[5]. inadequate means not enough good trials existed in 2019 to say either way. it does not mean those things were shown to fail. the recommendation is US-specific and now several years old.
medication, breastfeeding, and what this page will not do
the most searched question in this whole subject is whether you can be treated while breastfeeding. we are not going to answer it here, and the reason is that the evidence set behind this page is deliberately non-drug — it contains no medication trials, no lactation pharmacology, and nothing about drug transfer into milk. answering anyway would be exactly the kind of confident, unsourced sentence this site exists to avoid.
two things we will say. first: this is a prescriber conversation, and it is a real one — people have it every day and it has actual answers, specific to the drug, the dose, the age of your baby and your history. second: uncertainty about medication is not the same as a reason to go without help. counselling is the option with evidence on this page[3],[5], and it does not involve this trade-off at all. if you are already taking something, do not change it on the strength of a web page — that decision belongs with the person who prescribed it.
what to ask for
- will anyone screen me at my later appointments, or only at the six-week check? the risk runs across the whole first year.
- i have never had depression before — does that actually change how closely you will watch me?
- do i meet the USPSTF increased-risk criteria, and can you make the counselling referral now rather than waiting to see how i do?
- if i would rather try therapy than medication, can i be seen individually rather than in a group?
- if medication is on the table and i am breastfeeding, what are the specific trade-offs for this drug, at this dose, with a baby this age?
if you are still pregnant, the pregnancy page covers antenatal depression and anxiety, what the pooled evidence really says about birth outcomes, and the 10.4% of fathers who get depressed in the same window.
questions
how common is postpartum depression?
Pooling 565 studies of 1,236,365 women across 80 countries, 17.22% (95% CI 16.00–18.51) — roughly one in six new mothers. Rates vary enormously by place, up to 39.96% in Southern Africa. Most contributing studies used self-report screening scales rather than diagnostic interviews, so this is a symptom-threshold prevalence and runs higher than the rate of diagnosed major depression.
can postpartum depression start months after the birth?
Yes. In that same analysis prevalence stayed broadly flat across the first year — 17.70% at 1–3 months, 15.31% at 3–6 months, 18.19% at 6–12 months. It does not reliably fade after the early weeks, which is a problem when screening is concentrated at the six-week check.
I have never been depressed before. Does that protect me?
Less than people assume. Restricting to 58 studies of 37,294 mothers with no prior history of depression who delivered healthy full-term infants, prevalence was 17% (95% CI 15–20%) and the incidence of new cases 12% (95% CI 4–20%) — essentially the same as the all-comers figure. The incidence estimate has a very wide confidence interval.
does therapy work for postpartum depression?
Across 40 randomised and quasi-randomised trials of CBT during pregnancy and the first postpartum year, CBT significantly reduced depressive symptoms compared with control conditions, in both treatment and prevention trials. Interventions started after the birth outperformed those started during pregnancy, and in prevention trials one-to-one delivery beat group formats. The author notes methodological quality varied widely across the trials.
does peer support actually prevent postpartum depression?
In one multisite randomised trial of 701 Ontario mothers screened as high-risk, proactive telephone support from a trained volunteer who had herself recovered from postnatal depression cut the rate above the depression threshold at 12 weeks from 25% to 14% — a number needed to treat of 8.8. The difference was gone by 24 weeks, but that is because women found to be depressed at 12 weeks were referred for treatment for ethical reasons, which contaminates the later comparison. Resolv is a peer-support product, so treat that finding as one we have an interest in and read the trial yourself.
can postpartum depression be treated while breastfeeding?
That is a prescriber conversation, and it is the right question to ask them directly. The evidence set behind this page is deliberately non-drug: it does not include medication trials, so we will not tell you what is or is not safe in breastfeeding. What we will say is that the uncertainty about medication is not the same as a reason to go without help: counselling is the option with evidence on this page, and it does not involve that trade-off. The medication question belongs in a conversation with someone who knows your history, your baby and your prescription.
is there anything recommended before I get ill?
Yes. The US Preventive Services Task Force issued a B recommendation that clinicians provide or refer pregnant and postpartum people at increased risk of perinatal depression to counselling — finding convincing evidence that CBT and interpersonal therapy prevent it, with no more than small potential harms. Increased risk includes a history of depression, current depressive symptoms, or socioeconomic factors such as low income or young or single parenthood.
sources
primary sources only — no news write-ups, no secondary summaries. each was fetched and checked on the access date shown.
[1] Wang Z, Liu J, Shuai H, et al. Mapping global prevalence of depression among postpartum women. Translational Psychiatry, 2021. doi:10.1038/s41398-021-01663-6. PMID 34671011.
meta-analysis of 565 studies across 80 countries · n = 1,236,365 · evidence tier: strong · funding: independent — Chinese national and provincial public research funders · accessed August 18, 2026
the catch: Most contributing studies were cross-sectional and used self-report screening scales rather than diagnostic interviews, so this is a symptom-threshold prevalence and runs higher than the rate of diagnosed major depression. The article carries a published correction (PMID 34930896) — a correction, not a retraction.
[2] Shorey S, Chee CYI, Ng ED, Chan YH, Tam WWS, Chong YS. Prevalence and incidence of postpartum depression among healthy mothers: a systematic review and meta-analysis. Journal of Psychiatric Research, 2018. doi:10.1016/j.jpsychires.2018.08.001. PMID 30114665.
meta-analysis of 58 studies · n = 37,294 · evidence tier: moderate · funding: unknown — no funding statement was reachable · accessed August 18, 2026
the catch: The incidence estimate has a very wide confidence interval (4–20%), and prevalence differed sharply by region (26% in the Middle East versus 8% in Europe), so the single pooled number hides large real variation.
[3] Sockol LE. A systematic review of the efficacy of cognitive behavioral therapy for treating and preventing perinatal depression. Journal of Affective Disorders, 2015. doi:10.1016/j.jad.2015.01.052. PMID 25743368.
systematic review of 40 randomised and quasi-randomised trials · evidence tier: moderate · funding: unknown — no funding statement was reachable · accessed August 18, 2026
the catch: The author notes methodological quality varied widely across the included trials, and the pool mixes properly randomised with quasi-randomised studies. No pooled participant total or numeric effect size is reported in the record.
[4] Dennis CL, Hodnett E, Kenton L, et al. Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial. BMJ, 2009. doi:10.1136/bmj.a3064. PMID 19147637.
multisite randomised controlled trial (ISRCTN 68337727) · n = 701 · evidence tier: gold standard · funding: independent — Canadian Institutes of Health Research · accessed August 18, 2026
the catch: The between-group difference had disappeared by 24 weeks — but that is because women found to be depressed at 12 weeks were referred for treatment for ethical reasons, which contaminates the later comparison rather than showing the effect wore off. The trial found no benefit for loneliness or health-service use.
[5] US Preventive Services Task Force; Curry SJ, Krist AH, Owens DK, et al. Interventions to prevent perinatal depression: US Preventive Services Task Force recommendation statement. JAMA, 2019. doi:10.1001/jama.2019.0007. PMID 30747971.
national clinical guideline · evidence tier: gold standard · funding: independent — congressionally mandated, supported by AHRQ · accessed August 18, 2026
the catch: "Inadequate evidence" for exercise, education and the drug options means not enough good trials existed in 2019, not that those approaches were shown to fail. The recommendation is US-specific and now several years old.
the sentence you keep building and abandoning
resolv is free peer support, and you are anonymous to everyone you talk to. you post under a handle you pick — no real name, no phone number, nothing that follows you back to your real life 🤍
get resolv — it's freerelated on resolv
- sex, fertility, pregnancy, and mental health — the hub: what the research shows across sex, fertility, pregnancy and new parenthood — and where it runs out.
- ssri sexual side effects — the numbers nobody gave you — how common sexual side effects are when someone actually asks, what the trials found for sildenafil and bupropion, and what the eu regulator made manufacturers put on the label about symptoms that persist.
- infertility and depression — how common depression is during infertility, why "just relax" is not supported by the evidence, and what happens to people psychologically when treatment ends without a baby.
- after a miscarriage — post-traumatic stress, anxiety and depression after early pregnancy loss — how long it lasts, what happens to partners, and what the trials of one-off counselling did and did not settle.
- depression and anxiety in pregnancy — antenatal depression and anxiety: prevalence by trimester, what two meta-analyses found about birth outcomes, depression in fathers, and the trials of support offered to everyone rather than only the high-risk.
- postpartum depression support online
- new dad mental health
- how we score evidence
this is not medical advice. it is a summary of published research, it is not a diagnosis, and it is not a recommendation for or against any treatment — nobody here has met you. decisions about starting, changing or stopping a medication belong to you and a prescriber who knows your history. do not change a prescribed medication on the strength of a web page, this one included.
last verified . if a source is updated, corrected or retracted, this page gets changed and re-dated.